Recombinant Human Interferon-Gamma for the Adjuvant Treatment of High Risk Malignant Melanoma After Surgical Excision of the Primary Lesion

Comparison of survival outcomes among cancer patients treated in and out of clinical trials

J Unger;W Barlow;DP Martin;S Ramsey;M Leblanc;R Etzioni;D Hershman Journal of the National Cancer Institute 106(3):dju002; 2014 Mar 13 [Epub ahead of print];

PMid: PMID24627276 | PMC number: PMC3982777

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

Is interferon-g detrimental? Results of a Southwest Oncology Group randomized trial of adjuvant human interferon-g versus observation in malignant melanoma.

VK Sondak;KJ Kopecky;JW Smith II;EM Hersh;RD Noyes;RJ Tuthill;TP Miller;LG Feun;JH Doroshow;LE Flaherty;FL Meyskens Jr Adjuvant Therapy of Cancer VII, SE Salmon and DS Alberts eds 29:259-272

Adjuvant therapy for melanoma.

VK Sondak;JA Wolfe Current Opinion in Oncology 9:189-204

Is interferon-y detrimental? Results of a Southwest Oncology Group randomized trial of adjuvant human interferon-y versus observation in malignant melanoma.

VK Sondak;KJ Kopecky;JW Smith II;CW Taylor;RD Noyes;RJ Tuthill;EM Hersh;LG Feun;JD Doroshow;LE Flaherty;FL Meyskens Jr Proc of the 8th Intl Conference on the Adjuvant Therapy of Cancer :51(#31)

Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: A Southwest Oncology Group study.

FL Meyskens Jr;KJ Kopecky;CW Taylor;RD Noyes;RJ Tuthill;EM Hersh;LG Feun;JH Doroshow;LE Flaherty;VK Sondak Journal of the National Cancer Institute 87(22):1710-1713

A phase III trial of recombinant human interferon-gamma (IFN) as adjuvant therapy of high risk malignant melanoma (MM).

FL Meyskens;K Kopecky;M Samson;D Noyes;R Tuthill;E Hersh;J Macdonald;H Jaffe;J Crowley;C Coltman, Jr ASCO 10:291(#1019)

Recombinant human interferon y: Adverse effects in high risk stage I and II cutaneous malignant melanoma.

FL Meyskens, Jr;K Kopecky;M Samson;E Hersh;J Macdonald;H Jaffe;J Crowley;C Coltman, Jr JNCI 82(12):1071